666

3D GLOBAL BIOTECH INC

No trades
See on Supercharts
Market capitalization
‪2.15 B‬TWD
‪−67.09 M‬TWD
‪13.64 M‬TWD
Beta (1Y)
0.27

About 3D GLOBAL BIOTECH INC

CEO
Keng Liang Ou
Headquarters
New Taipei
Founded
2014
ISIN
TW0006808009
FIGI
BBG00YJ9NG04
3D Global Biotech, Inc. engages in the research and development of biological three dimensional printing technology. It also sells medical equipment. It provides cranial implant customized services, entrusted technical services, and oral medical materials customized services. It offers soft tissue and hard tissue reconstruction medical products including bio-hydrogel ink and corneal epithelial reconstruction, orthopedic reconstruction, dental and jaw reconstruction, and skull reconstruction products. The company was founded on December 26, 2014 and is headquartered in New Taipei, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 6808 is 31.55 TWD — it has decreased by 1.87% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange 3D GLOBAL BIOTECH INC stocks are traded under the ticker 6808.
6808 stock is 9.08% volatile and has beta coefficient of 0.27. Check out the list of the most volatile stocks — is 3D GLOBAL BIOTECH INC there?
Yes, you can track 3D GLOBAL BIOTECH INC financials in yearly and quarterly reports right on TradingView.
6808 stock has risen by 3.44% compared to the previous week, the month change is a 1.61% rise, over the last year 3D GLOBAL BIOTECH INC has showed a 4.82% increase.
6808 net income for the last quarter is ‪−27.70 M‬ TWD, while the quarter before that showed ‪−30.26 M‬ TWD of net income which accounts for 8.46% change. Track more 3D GLOBAL BIOTECH INC financial stats to get the full picture.
No, 6808 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6808 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 3D GLOBAL BIOTECH INC stock right from TradingView charts — choose your broker and connect to your account.
6808 reached its all-time high on Dec 25, 2020 with the price of 76.00 TWD, and its all-time low was 17.20 TWD and was reached on Oct 11, 2023.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 3D GLOBAL BIOTECH INC technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 3D GLOBAL BIOTECH INC stock shows the buy signal. See more of 3D GLOBAL BIOTECH INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 3D GLOBAL BIOTECH INC EBITDA is ‪−39.96 M‬ TWD, and current EBITDA margin is −193.67%. See more stats in 3D GLOBAL BIOTECH INC financial statements.